Measurement of selected ions related to oxidative stress and energy metabolism in Saudi autistic children

Clinical Biochemistry

Volumn 43, Issue 1-2, 2010, Pages 63-70

  El Ansary, Afaf ^a   Al Daihan, S ^a   Al Dbass, A ^a   Al Ayadhi, L ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Calcium; Energy metabolism; Lead; Lipid peroxides; Magnesium; Na+ K+ pump; Oxidative stress; Potassium; Sodium

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CALCIUM; LEAD; MAGNESIUM; MALONALDEHYDE; POTASSIUM; SODIUM;

ADOLESCENT; ARTICLE; AUTISM; CALCIUM BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ENERGY METABOLISM; ENZYME ACTIVITY; FEMALE; HUMAN; LEAD BLOOD LEVEL; LIPID PEROXIDATION; MAGNESIUM BLOOD LEVEL; MALE; MITOCHONDRIAL RESPIRATION; OXIDATIVE STRESS; PATHOGENESIS; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SAUDI ARABIA; SODIUM BLOOD LEVEL;

AUTISTIC DISORDER; CHILD; ENERGY METABOLISM; HUMANS; IONS; LIPID PEROXIDATION; MALONDIALDEHYDE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SAUDI ARABIA; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 72649091920     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.09.008     Document Type: Article

References (74)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. DSM-IV. 4th ed. (1994), American Psychatric Association, Washington, DC
2. Moldin S.O., Rubenstein J.L.R., and Hyman S.E. Can autism speak to neuroscience. J. Neurosci. 26 (2006) 6893-6896
3. DiCicco-Bloom E., Lord C., Zwaigenbaum L., et al. The developmental neurobiology of autism spectrum disorder. J. Neurosci. 26 (2006) 6897-6906
4. Kanner L. Autistic disturbances of affective contact. Nerv. Child. 2 (1943) 217-250
5. McCaffery P., and Deutsch C.K. Macrocephaly and the control of brain growth in autistic disorders. Prog. Neurobiol. 77 (2005) 38-56
6. Palmen S.J.M.C., van Engeland P.R., Hof P.R., and Schmitz C. Neuropathological findings in autism. Brain 127 (2004) 2572-2583
7. Bauman M.L., and Kemper T.L. Neuroanatomic observations of the brain in autism: a review and future directions. Int. J. Dev. Neurosci. 23 (2005) 183-187
8. Pickett J., and London E. The neuropathology of autism: a review. J. Neuropathol. Exp. Neurol. 64 (2005) 925-935
9. Ames III A. CNS energy metabolism as related to function. Brain Res. 34 (2000) 42-68
10. Atwell D., and Laughlin S.B. An energy budget for signaling in the grey matter of the brain. J. Cereb. Blood Flow Metab. 21 (2001) 1133-1145
11. Erecinska M., and Silver I.A. ATP and brain function. J. Cereb. Blood Flow Metab. 9 (1989) 2-19
12. Drachman D.A., Noffsinger D., Sahakian B.J., Kurdziel S., and Fleming P. Aging, memory and the cholinergic system: a study of dichotonic listening. Neurobiol. Aging 1 (1980) 39-43
13. Lynch G., and Baudry M. The biochemistry of memory: a new and specific hypothesis. Science 224 (1984) 1057-1063
14. Pickett J., and London E. The neuropathology of autism: a review. J. Neuropathol. Exp. Neuro. 64 (2005) 925-935
15. Kaziro Y. The role of GTP in polypeptide chain elongation. Biochim. Biophys. Acta 505 (1978) 95-127
16. Okada M., Ishikawa M., and Mizushima Y. Identification of a ubiquitin- and ATP-dependent protein degradation pathway in rat cerebral cortex. Biochim. Biophys. Acta 1073 (1991) 514-520
17. Huganir R.L., and Greengard P. Regulation of neurotransmitter receptor desensitization by protein phosphorylation. Neuron 5 (1990) 555-567
18. Silver I.A., and Erecin ́ska M. Energetic demand of the Na1/K1 ATPase in mammalian astrocytes. Glia 21 (1997) 35-45
19. Gilman A.G. G protein: transducers of receptor-generated signals. Ann. Rev. Biochem. 56 (1987) 615-649
20. Jorgensen P.L., Ha°kansson K.O., and Karlish S.J. Structure and mechanism of Na,K-ATPase: functional sites and their interactions. Annu. Rev. Physiol. 65 (2003) 817-849
21. Kaplan J.H. Biochemistry of Na,K-ATPase. Annu. Rev. Biochem. 71 (2002) 511-535
22. Skou J.C., and Esmann M. The Na,K-ATPase. J. Bioenerg. Biomembr. 24 (1992) 249-261
23. Castaldo P., Cataldi M., Magi V., Lariccia S., Arcangeli S., and Amsoroso S. Role of the mitochondrial sodium/calcium exchanger in neuronal physiology and in the pathogenesis of neurological diseases. Prog. Neurobiol. 87 1 (2009) 58-79
24. Fernandez G.O., Martinez R.R., Palazuelos E., and Fortoul T. High blood lead levels in ceramic folk art workers in Michoacan, Mexico. Arch. Environ. Health 52 (1997) 51-55
25. Hirata M., Yoshida T., Miyajima K., Kosaka H., and Tabuchi T. Correlation between lead in plasma and other indicators of lead exposure among lead-exposed workers. Int. Arch. Occup. Environ. Health 68 (1995) 58-63
26. Lo ́pez-Carrillo L., Torres-Sa ́nchez L., Garrido F., Papaqui-Herna ́ndez J., Palazuelos-Rendo ́n E., and Lo ́pez-Cervantes M. Prevalence and determinants of lead intoxication in Mexican children of low socioeconomic status. Environ. Health Perspect. 104 (1996) 1208-1211
27. Rothenberg S.J., Williams F.A., Delrahim S., et al. Blood lead levels in children in south central Los Angeles. Arch. Environ. Health 51 (1996) 383-388
28. Hoyer S. Models of Alzheimer's disease: cellular and molecular aspects. J. Neural. Transm. 49 (1997) 11-21
29. Heo J.H., et al. Free radicals as triggers of brain edema formation after stroke. Free Radic. Biol. Med. 39 (2005) 51-70
30. Chan P.H. Reactive oxygen radicals in signaling and damage in the ischemic brain. J. Cereb. Blood. Flow. Metab. 21 (2001) 2-14
31. R.K. Rao, S. Basuroy, V.U. Rao, K.J. Karnaky, Jr, A. Gupta, Tyrosine phosphorylation and dissociation of occludin-ZO-1 and E-cadherin-beta-catenin complexes from the cytoskeleton by oxidative stress. Biochem. J. 368, 471-481.
32. Schreibelt G., et al. Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB J. 21 (2007) 3666-3676
33. Sheth P., et al. Role of phosphatidylinositol 3-kinase in oxidative stress-induced disruption of tight junctions. J. Biol. Chem. 278 (2003) 49239-49245
34. Sajdel-Sulkowska E.M., Xu M., and Koibuchi N. Increase in cerebellar neurotrophin-3 and oxidative stress markers in autism. Cerebellum 8 3 (2009) 366-372
35. Ruize-Larrea M.B., Leal A.M., Liza M., and Lacort M. Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsome. Steroids 59 (1994) 383-385
36. +ATPase inhibition by arterial natriuretic factor in rat renal medulla. J. Physiol. Pharmacol. 49 (1998) 625-637
37. Fiske C.H., and Subbarow Y. The colorimetric determination of phosphorous. J. Biol. Chem. 66 (1925) 375-400
38. Faulker W.R., and Meites S. Selected methods for the small clinical chemistry laboratory (1982) 125 Washington, DC
39. Henry R.F., et al. Clinical Chemistry Principles and Techniques. 2nd ed. (1974), Harper and Row, Hagerstown, MD
40. N.W. Tietz, Fundamentals of Clinical Chemistry, W.B., Saunder Co., Philadelphia, PA, 874.
41. Lindstrom F., and Diehl H. Anal. Chem. 32 (1960) 1123
42. Klein B., and Oklander M. Clin. Chem. 13 (1976) 26
43. Shohami E., Beit-Yannai E., Horowitz M., and Kohen R. Oxidative stress in closed-head injury: brain antioxidant capacity as an indicator of functional outcome. J. Cereb. Blood Flow Metab. 17 (1997) 1007-1019
44. Barbouti A., Doulias P.T., Nousis L., Tenopoulou M., and Galaris D. DNA damage and apoptosis in hydrogen peroxide-exposed Jurkat cells: bolus addition versus continuous generation of H2O2, Free Radic. Biol. 33 (2002) 691-702
45. Deshpande S.S., and Irani K. Oxidant signalling in carcinogenesis: a commentary. Hum. Exp. Toxicol. 21 (2002) 63-64
46. Jin N., Hatton N.D., Harrington M.A., Xia X., Larsen S.H., and Rhoades R.A. H2O2-induced egr-1, fra-1, and c-jun gene expression is mediated by tyrosine kinase in aortic smooth muscle cells, Free Radic. Biol. Med. 29 (2000) 736-746
47. Chauhan A., Chauhan V., Brown W.T., and Cohen L. Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin the antioxidant proteins. Life Sci. 75 (2004) 2539-2549
48. Hye A., Lynham S., Thambisetty M., et al. Proteome-based plasma biomarkers for Alzheimer's disease. Brain 129 Pt. 11 (2006) 3042-3050
49. Erecinska M., Cherian1 S., and Silver I.A. Energy metabolism in mammalian brain during development. Prog. Neurobiol. 73 (2004) 397-445
50. Lees G.J. Contributory mechanisms in the causation of neurodegenerative disorders. Neuroscience 54 (1993) 287-322
51. Behl C., Davis J.B., Lesley R., and Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77 (1994) 817-827
52. Dreher D., and Junod A.F. Differential effects of superoxide, hydrogen peroxide, and hydroxyl radical on intracellular calcium in human endothelial cells. J. Cell. Physiol. 162 (1995) 147-153
53. 2+ stores and protein synthesis in human endothelial cells. Circ. Res. 76 (1995) 388-395
54. 2+] of cultured rat arterial smooth muscle cells. Biochem. Biophys. Res. Commun. 209 (1995) 139-145
55. Green C.J., Gower J.D., Healing G., Cotterill L.A., Fuller B.J., and Simpkin S. The importance of iron, calcium and free radicals in reperfusion injury: an overview of studies on ischaemic rabbit kidney. Free Radic. Res. Commun. 7 (1989) 255-264
56. 2+] in canine cerebral arterial smooth muscle: 1999;360:646-653
57. Al-Gadani Y., El-Ansary A., Attas O., and Al-Ayadhi L. Oxidative stress and antioxidant status in Saudi autistic children. Clin. Biochem 42 (2009) 1032-1040
58. Geier D.A., and Geier M.R. A clinical and laboratory evaluation of methionine cycletranssulfuration and androgen pathway markers in children with autistic disorders. Horm. Res. 66 (2006) 182-188
59. Geier D.A., and Geier M.R.A. case series of children with apparent mercury toxic encephalopathies manifesting with clinical symptoms of regressive autistic disorders. J. Toxicol. Environ. Health, A. 70 (2007) 837-851
60. Geier D.A., Kern J.K., Garver C.R., Adams J.B., Audhya T., and Geier M.R. A prospective study of transsulfuration biomarkers in autistic disorders. Neurochem. Res. 34 (2009) 386-393
61. Krey J.F., and Dolmetsch R.E. Molecular mechanisms of autism: a possible role for Ca 2+ signaling. Curr. Opin. Neurobiol. 17 (2007) 112-119
62. Volkmar F.R., and Nelson D.S. Seizure disorders in autism. J. Am. Acad. Child. Adolesc. Psychiatry 29 (1990) 127-129
63. Tuchman R.F., Rapin I., and Shinnar S. Autistic and dysphasic children. II: epilepsy. Pediatrics 88 (1991) 1219-1225
64. Tuchman R.F., and Rapin I. Epilepsy in autism. Lancet Neurol. 1 (2002) 352-358
65. Clarke D.F., Roberts W., Daraksan M., et al. The prevalence of autistic spectrum disorder in children surveyed in a tertiary care epilepsy clinic. Epilepsia 46 (2005) 1970-1977
66. Oliveira G., Diogo L., Grazina M., et al. Mitochondrial dysfunction in autism spectrum disorders: a population-based study. Dev. Med. Child. Neurol. 47 (2005) 185-189
67. Muhle R., trentacoste S.V., and Rapin I. The genetics of autism. Pediatrics 26 (2004) 599-625
68. Galland L. Magnesium, stress and neuropsychiatric disorders. Magnes. Trace Elem. 10 2-4 (1992) 287-301
69. 2+ in human brain and skeletal muscle by 31P-MRS. Magnes. Res. 21 3 (2008) 157-162
70. Al-Mosalim O., El-Ansary A., Attas O., and Al-Ayadhi L. Selected enzymes related to energy metabolism in Saudi autistic children. Clin. Biochem. 42 (2009) 949-957
71. Strambi M., Longini M., Hayek J., et al. Magnesium profile in autism. Biol. Trace Element Res. 109 2 (2006) 97-104
72. Scortegagna M., Chikhale E., and Hanbauer I. Lead exposure increases oxidative stress in serum derived E14 mesencephalic cultures. Role of metalothionein and glutathione. Restor. Neurol. Neurosci. 12 (1998) 95-101
73. Almeida A., Heales S.J.R., Bolanos J.P., and Medina J.M. Glutamate neurotoxicity is associated with nitric oxide-mediated mitochondrial dysfunction and glutathione depletion. Brain Res. 790 (1998) 209-216
74. Rothenberg S.J., Williams F.A., Delrahim S., et al. Blood lead levels in children in south central Los Angeles. Arch. Environ. Health 51 (1996) 383-388